The Silicon Valley startup plans to start its registration-directed study of Limbix Spark in the earlier part of next year and - if successful - would anticipate FDA clearance in early 2022.
The INVEST Digital Health Virtual conference Pitch Perfect competition, from September 21-25, had some intense competition between the healthcare startup participants. Thanks to all the entrepreneurs, judges and sponsors who took part.
Limbix CMO Dr. Cruz discusses the difference between 510(k) clearances and enforcement discretions, and why research should go beyond the FDA threshold.
The West Coast Consortium for Technology & Innovation in Pediatrics (CTIP) announced in April the launch of its COVID-19 FlexGrants
GSR Ventures led the round with participation from Sequoia Capital, Storm Ventures, NextGen Venture Partners and BIXINK Therapeutics.
The new funding enables further research and development of the company’s flagship product, Limbix Spark, the first prescription digital therapeutic designed to treat adolescents with depression.May 6, 2020
Welcome to #TheNextWave, a conversation series with the Headstream Accelerator Finalists who want to use social tech for the good of humanity.
This year's cohort includes 27 companies that are working on everything from digital therapeutics to care coordination tools, to clinician workflow platforms, to opioid alternatives.
Clinical study tech company TrialSpark teamed up with digital mental health firm Limbix to work on a new “digital therapeutic” for adolescent depression.
For media inquiries and our press kit, please contact press@limbix.com
.png)
